Evidence map›Paper›PMID 32064346›Full record

ArticleScience advances2020

Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity.

Xiao Ma, Ping Zhu, Yonghe Ding, Hong Zhang, Qi Qiu, Alexey V Dvornikov, Zheng Wang, Maengjo Kim, Yong Wang, Matthew Lowerison and 7 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. miScience · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Circulation research · 2021
    Article
  18. Article
  19. Review
  20. Disruption ofBioMed research international · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Xiao MaDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-9940-8468
Ping ZhuDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Yonghe DingDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Hong ZhangDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-4116-7347
Qi QiuDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-7756-7134
Alexey V DvornikovDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-1514-4747
Zheng WangDepartment of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-6002-5299
Maengjo KimDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Yong WangDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Matthew LowerisonDepartment of Urology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-1125-4554
Yue YuDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Nadine NortonDepartment of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
Joerg HerrmannDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Stephen C EkkerDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-0726-4212
Tzung K HsiaiSchool of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Xueying LinDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Xiaolei XuDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-4928-3422
Mayo Clinic in Arizona · USMayo Clinic · USMayo Clinic in Florida · USBeijing University of Chinese Medicine · CNCapital Medical University · CNCentral South University · CNUniversity of California, Los Angeles · US

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
Institutional Career Development CoreKL2TR002379 · NCATS · MAYO CLINIC ROCHESTER · PI NILUFER ERTEKIN-TANER · 2017 to 2026
$14.9M
Systematic Vertebrate Functional GenomicsR01GM063904 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI EKKER, STEPHEN CARL · 2001 to 2025
$10.7M
Genetic Studies of Sarcomere-based Cardiac Diseases (Diversity Supplement)R01HL081753 · NHLBI · MAYO CLINIC ROCHESTER · PI XU, XIAOLEI · 2005 to 2025
$7.8M
Epicardial remodeling in cardiomyopathy and cardiac agingR01HL107304 · NHLBI · MAYO CLINIC ROCHESTER · PI Xiaolei Xu · 2011 to 2026
$6.6M
International Zebrafish Mutagenic Protein TrapR01HG006431 · NHGRI · MAYO CLINIC ROCHESTER · PI EKKER, STEPHEN CARL · 2011 to 2016
$3.3M
Micro-Sensors to Study Electrical and Mechanical Coupling of Injured MyocardiumR01HL111437 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HSIAI, TZUNG K, XU, XIAOLEI · 2012 to 2020
$3.1M
Systematic Vertebrate Functional GenomicsR56GM063904 · NIGMS · MAYO CLINIC ROCHESTER · PI EKKER, STEPHEN CARL · 2009 to 2010
$611k
NCATS NIH HHS KL2 TR002379NCATS NIH HHS UL1 TR002377NCRR NIH HHS M01 RR000585NHGRI NIH HHS R01 HG006431NHLBI NIH HHS R01 HL081753NHLBI NIH HHS R01 HL107304NHLBI NIH HHS R01 HL111437NIGMS NIH HHS R01 GM063904NIGMS NIH HHS R56 GM063904
6 · The paper itself

Abstract

To uncover the genetic basis of anthracycline-induced cardiotoxicity (AIC), we recently established a genetic suppressor screening strategy in zebrafish. Here, we report the molecular and cellular nature of

Indexed as

AnimalsBexaroteneCardiotonic AgentsCardiotoxicityDisease Models, AnimalEndothelial CellsHeartHumansIsotretinoinMyocardiumNeoplasmsPericardiumRetinoid X Receptor alphaZebrafishZonula Occludens-1 ProteinBexaroteneCardiotonic AgentsIsotretinoinRetinoid X Receptor alphaRXRA protein, humanZonula Occludens-1 Protein

Identifiers

PMID32064346
PMCPMC6989136
OpenAlexW3004204848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.